An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Clinical trial NCT00930553 · COMPLETED
Trial details
- NCT number
- NCT00930553
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2016-02-01
- Enrollment
- 1314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.